Skip to content

Contact

Every conversation gets a named owner.

We are a small team in controlled early access — mail is read by the people who build the platform, and we reply either way.

  • Research teams

    Supported analyses, assurance profiles, onboarding for labs and core facilities.

    contact@genomarker.com
  • Platform & agent partnerships

    Assurance API, MCP surface, and embedding evidence in your product.

    contact@genomarker.com
  • Diligence engagements

    Independent review of computational claims for investors and BD teams.

    contact@genomarker.com
  • Investors & programs

    Incubators, accelerators, grants, and fellowship conversations.

    contact@genomarker.com
  • Security & disclosure

    Signing keys, evidence integrity, responsible disclosure.

    contact@genomarker.com

REPLIES WITHIN 5 BUSINESS DAYS

Or write to us here

Routed by topic to the right owner.

ResearchPartnershipDiligenceInvestmentOther
Read by a human. We reply either way.